These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12757252)

  • 1. Imiquimod.
    Skinner RB
    Dermatol Clin; 2003 Apr; 21(2):291-300. PubMed ID: 12757252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod as an immune response modulator in infectious conditions.
    Skinner RB
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.
    Yan J; Chen SL; Wang HN; Wu TX
    Dermatology; 2006; 213(3):218-23. PubMed ID: 17033171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
    Hengge UR; Cusini M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod in clinical practice.
    Edwards L
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S12-7. PubMed ID: 10861102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod: a review.
    Gupta AK; Browne M; Bluhm R
    J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod; an international update on therapeutic uses in dermatology.
    Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
    Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod as a dermatological therapy.
    Tran H; Moreno G; Shumack S
    Expert Opin Pharmacother; 2004 Feb; 5(2):427-38. PubMed ID: 14996638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond a decade of 5% imiquimod topical therapy.
    A Gaspari A; Tyring SK; Rosen T
    J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod.
    Garland SM
    Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imiquimod (Aldara): modifying the immune response.
    Rudy SJ
    Dermatol Nurs; 2002 Aug; 14(4):268-70. PubMed ID: 12240505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The imidazoquinolines and their place in the therapy of cutaneous disease.
    Smith KJ; Hamza S; Skelton H
    Expert Opin Pharmacother; 2003 Jul; 4(7):1105-19. PubMed ID: 12831337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
    Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
    Schöfer H
    Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using imiquimod for genital warts in female patients.
    Cox JT; Petry KU; Rylander E; Roy M
    J Womens Health (Larchmt); 2004 Apr; 13(3):265-71. PubMed ID: 15130255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
    Vexiau D; Decuypère L; Moyse D; Aractingi S
    Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
    Garland SM; Sellors JW; Wikstrom A; Petersen CS; Aranda C; Aractingi S; Maw RD;
    Int J STD AIDS; 2001 Nov; 12(11):722-9. PubMed ID: 11589811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
    Pachman DR; Barton DL; Clayton AC; McGovern RM; Jefferies JA; Novotny PJ; Sloan JA; Loprinzi CL; Gostout BS
    Am J Obstet Gynecol; 2012 Jan; 206(1):42.e1-7. PubMed ID: 21907959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.